-+ 0.00%
-+ 0.00%
-+ 0.00%

Eupraxia names Jeff Millard EVP technical operations as Amanda Malone steps down COO

PUBT·07/13/2026 20:06:00
Listen to the news
Eupraxia names Jeff Millard EVP technical operations as Amanda Malone steps down COO
  • Eupraxia named Jeff Millard executive vice president, technical operations, effective July 13, 2026.
  • Millard brings nearly 25 years in technical operations, CMC, regulatory strategy; held senior roles at Ensysce Biosciences, Microbion, Cascadian Therapeutics.
  • Alex Therien was appointed executive vice president, research and development; joined in November 2025 from leadership roles at Generate Biomedicines, Eikon, Merck.
  • Amanda Malone stepped down as chief scientific and operating officer, effective July 10, 2026.
  • Operations shifted from Victoria to Vancouver, Seattle; key clinical, manufacturing, commercial leadership including the CEO to be based in Seattle.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eupraxia Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607131605PRIMZONEFULLFEED9761369) on July 13, 2026, and is solely responsible for the information contained therein.